本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cogent Biosciences, Inc.

12.07
-0.1200-0.98%
盘后:12.310.2400+1.99%18:38 EDT
成交量:176.38万
成交额:2,124.48万
市值:16.84亿
市盈率:-5.92
高:12.21
开:12.15
低:11.84
收:12.19
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/07

重要事件披露

Form 8-K - Current report
2023/06/07

重要事件披露

Form 8-K - Current report
2023/06/05

重要事件披露

Form 8-K - Current report
2023/05/31

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/13

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”